Nobuhiro Nishii

Nobuhiro Nishii

Auto-generated profile, based on publicly available information

Nobuhiro Nishii

Department of Cardiovascular Therapeutics Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Circulation Journal
Verified
Journal Article
Open access
PDF file
NNNobuhiro Nishii
Nobuhiro Nishii
MOMasahiro Ogawa
Masahiro Ogawa
HMHiroshi Morita
Hiroshi Morita
Kazufumi NakamuraKazufumi Nakamura
Kazufumi Nakamura
KBKimikazu Banba
Kimikazu Banba
HIHiroshi Ito
Hiroshi Ito
Background: Mutations in SCN5A are reportedly linked to Brugada syndrome (BS), but recent observations suggest that they are not necessarily associated with ventricular fibrillation (VF) in BS patients. Therefore, the clinical importance of SCN5A mutations in BS patients was examined in the present study. Methods and Results: The 108 BS patients were examined for SCN5A mutations and various parameters were compared between patients with and without mutations. An implantable cardioverter defibrillator (ICD) was implanted in 49 patients and a predictor of appropriate ICD shock was investigated. The existence of a SCN5A mutation was not associated with initial VF episodes (21.7% vs 20.0%, P=0.373). In the secondary prevention group, appropriate shock-free survival rate was significantly lower in patients with spontaneous type 1 ECG than in those without (41.1% vs 85.7% at 2 years, P=0.014). The appropriate shock-free survival rate was also significantly lower in patients with SCN5A mutations than in those without (28.6% vs 83.3% at 1 year, P=0.040). Appropriate shock was more frequent in patients with SCN5A mutations than in those without (6.6±6.2 vs 1.7±3.0, P=0.007). Conclusions: SCN5A mutations are associated with early and frequent VF recurrence, but not with initial VF episodes. This is the first report on the genotype-phenotype interaction and clinical significance of this mutation. (Circ J 2010; 74: 2572-2578)

1 August 2017 in International Journal of Cardiology
Verified
Journal Article
Closed access
YTYoichi Takaya
Yoichi Takaya
KKKengo Kusano
Kengo Kusano
NNNobuhiro Nishii
Nobuhiro Nishii
Kazufumi NakamuraKazufumi Nakamura
Kazufumi Nakamura
HIHiroshi Ito
Hiroshi Ito

17 January 2010 in EP Europace
Verified
Journal Article
Open access
PDF file
NNNobuhiro Nishii
Nobuhiro Nishii
SNSatoshi Nagase
Satoshi Nagase
HMHiroshi Morita
Hiroshi Morita
KKKengo Fukushima Kusano
Kengo Fukushima Kusano
TNTsunetoyo Namba
Tsunetoyo Namba
TOTohru Ohe
Tohru Ohe
This study sought to examine the action potential duration restitution (APDR) property and conduction delay in Brugada syndrome (BrS) patients. A steeply sloped APDR curve and conduction delay are known to be important determinants for the occurrence of ventricular fibrillation (VF). Endocardial monophasic action potential was obtained from 39 BrS patients and 9 control subjects using the contact electrode method. Maximum slopes of the APDR curve were obtained at both the right ventricular outflow tract (RVOT) and the right ventricular apex (RVA). The onset of activation delay (OAD) after premature stimulation was examined as a marker of conduction delay. Maximum slope of the APDR curve in BrS patients was significantly steeper than that in control subjects at both the RVOT and the RVA (0.77 ± 0.21 vs. 058 ± 0.14 at RVOT, P = 0.009; 0.98 ± 0.23 vs. 0.62 ± 0.16 at RVA, P = 0.001). The dispersion of maximum slope of the APDR curve between the RVOT and the RVA was also larger in BrS patients than in control subjects. The OAD was significantly longer in BrS patients than in control subjects from the RVOT to RVA and from the RVA to RVOT (from RVOT to RVA: 256 ± 12 vs. 243 ± 7 ms, P = 0.003; from RVA to RVOT: 252 ± 11 vs. 241 ± 9 ms, P = 0.01). Abnormal APDR properties and conduction delay were observed in BrS patients. Both repolarization and depolarization abnormalities are thought to be related to the development of VF in BrS patients.

18 December 2017 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
NNNobuhiro Nishii
Nobuhiro Nishii
AMAkihito Miyoshi
Akihito Miyoshi
MKMotoki Kubo
Motoki Kubo
MMMasakazu Miyamoto
Masakazu Miyamoto
YMYoshimasa Morimoto
Yoshimasa Morimoto
HIHiroshi Ito
Hiroshi Ito

1 January 2015 in Circulation Journal
Verified
Journal Article
Closed access
PDF file
TWTadashi Wada
Tadashi Wada
SNSatoshi Nagase
Satoshi Nagase
HMHiroshi Morita
Hiroshi Morita
KNKoji Nakagawa
Koji Nakagawa
NNNobuhiro Nishii
Nobuhiro Nishii
TOTohru Ohe
Tohru Ohe
Background:Brugada syndrome (BrS)-type electrocardiogram (ECG) is concealed by complete right bundle-branch block (CRBBB) in some cases of BrS. Clinical significance of BrS masked by CRBBB is not well known.Methods and Results:We reviewed an ECG database of 326 BrS patients who had type 1 ECG with or without pilsicainide. “BrS masked by CRBBB” was defined on ECG as <2-mm elevation of the J point at the time of CRBBB in the right precordial leads, and BrS-type J-point elevation ≥2 mm at the time of normalized QRS complex on relieved CRBBB. We identified 25 BrS patients (7.7%) with persistent (n=12) or intermittent CRBBB (n=13). Relief of CRBBB by pacing was performed in patients with persistent CRBBB. The prevalence of BrS masked by CRBBB was 3.1% (10/326 patients). Three patients had type 1 ECG, and 7 patients had type 2 or 3 ECG on relief of CRBBB. Two of these 10 patients had lethal arrhythmic events during the follow-up period (mean, 86.4±57.2 months). There was no prognostic difference between BrS masked by CRBBB and other BrS.Conclusions:In a small BrS population, CRBBB can completely mask typical BrS-type ECG. BrS masked by CRBBB is associated with the same risk of fatal ventricular tachyarrhythmia as other BrS. (Circ J 2015; 79: 2568–2575)

21 April 2022 in Journal of Arrhythmia
Verified
Journal Article
Open access
MSMorio Shoda
Morio Shoda
KKKengo Kusano
Kengo Kusano
MGMasahiko Goya
Masahiko Goya
NNNobuhiro Nishii
Nobuhiro Nishii
KIKatsuhiko Imai
Katsuhiko Imai
JIJ‐LEX registry investigators
J‐LEX registry investigators
The Japanese Heart Rhythm Society established a nationwide, mandatory, multi‐center, prospective, observational registry of transvenous lead extraction (TLE) named the Japanese lead extraction registry (J‐LEX) in 2018. We have published the first annual report of J‐LEX with 661 cases from 42 hospitals. The second annual report of J‐LEX in 2020 enrolled increased numbers of 785 cases from 75 hospitals. TLE procedure was attempted on patients with an average age of 71.7 years old, male in 72.5% in the hybrid operating room in 57.9%, and in standard OR with a C‐arm fluoroscope in 18.7%. The indication of TLE was an infection in 62.8% and the guideline classification was class‐I in 67.4% and class‐IIa in 23.8%. The average implantation duration of target leads was 7.9 years. Complete removal was achieved in 96.6% of the target leads and clinical success in 98.1% of the patients. Perioperative complications were observed in 7.1% of the patients. One patient died during a TLE operation and the other three patients died in‐hospital (cardiac death in one patient and non‐cardiac in two patients). Although the annual J‐LEX report in 2020 demonstrated an increased number of TLE procedures despite the first pandemic year of coronavirus disease‐2019 (COVID‐19), perioperative complications increased a little in comparison with J‐LEX 2019.